PD-1 blockade in Chinese versus Western patients with melanoma Editorial


Authors: Shoushtari, A. N.; Bao, R.; Luke, J. J.
Title: PD-1 blockade in Chinese versus Western patients with melanoma
Abstract: In this trial of programmed cell death-1 (PD-1) blockade with toripalimab in previously treated Chinese patients with melanoma, unique histologic and molecular features may explain why the objective response rate is lower than those defined in Western populations. This work suggests future avenues for investigating mechanisms of melanoma formation and resistance to PD-1 blockade.
Keywords: chemotherapy
Journal Title: Clinical Cancer Research
Volume: 26
Issue: 16
ISSN: 1078-0432
Publisher: American Association for Cancer Research  
Date Published: 2020-08-15
Start Page: 4171
End Page: 4173
Language: English
ACCESSION: WOS:000558688100001
DOI: 10.1158/1078-0432.Ccr-20-1558
PROVIDER: wos
PMCID: PMC7442612
PUBMED: 32487680
Notes: Editorial Material -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors